Back to Search Start Over

Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method.

Authors :
Lee VS
Patel P
O'Brien D
Scangas GA
Campbell RG
Chandra R
Davis GE
Han JK
Le CH
Lee J
Luong AU
Poetker DM
Ramadan H
Setzen M
Smith K
Wise S
Villwock J
Ference E
Source :
International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2022 Oct; Vol. 12 (10), pp. 1225-1231. Date of Electronic Publication: 2022 Jul 05.
Publication Year :
2022

Abstract

Absorbable steroid-eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delphi process on the indications and optimal timing for intraoperative or in-office placement of these implants. Six of a total of 12 statements reached consensus and were accepted. Overall, experts largely agree that intraoperative or in-office use of steroid-eluting stents could be considered for patients: (1) who are diabetic or intolerant of oral steroids, (2) undergoing extended frontal sinus surgery, and (3) with recurrent stenosis. Given the lack of expert consensus on other key statements, clinicians should carefully consider these treatment options on a case-by-case basis after shared decision-making.<br /> (© 2022 ARS-AAOA, LLC.)

Details

Language :
English
ISSN :
2042-6984
Volume :
12
Issue :
10
Database :
MEDLINE
Journal :
International forum of allergy & rhinology
Publication Type :
Academic Journal
Accession number :
35730163
Full Text :
https://doi.org/10.1002/alr.23044